Pacific Biosciences of California Inc logo

Pacific Biosciences of California Inc

1
NAS:PACB (USA)  
$ 2.84 -0.335 (-10.57%) 11:09 PM EST
At Loss
P/B:
1.21
Market Cap:
$ 849.41M
Enterprise V:
$ 1.15B
Volume:
8.61M
Avg Vol (2M):
8.21M
Also Trade In:
Volume:
8.61M
At Loss
Avg Vol (2M):
8.21M

Business Description

Pacific Biosciences of California Inc logo
Pacific Biosciences of California Inc
NAICS : 325413 SIC : 3845
ISIN : US69404D1081
Description
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Name Current Vs Industry Vs History
Cash-To-Debt 0.68
Equity-to-Asset 0.4
Debt-to-Equity 1.33
Debt-to-EBITDA -3.36
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1
Distress
Grey
Safe
Beneish M-Score -1.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.8
9-Day RSI 31.36
14-Day RSI 32.08
6-1 Month Momentum % -52.51
12-1 Month Momentum % -66.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.81
Quick Ratio 7.21
Cash Ratio 6.64
Days Inventory 150.64
Days Sales Outstanding 50.79
Days Payable 38.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.7
Shareholder Yield % -20.88

Financials (Next Earnings Date:2024-05-02 Est.)

PACB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PACB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Pacific Biosciences of California Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 200.521
EPS (TTM) ($) -1.21
Beta 2.25
Volatility % 77.26
14-Day RSI 32.08
14-Day ATR ($) 0.313416
20-Day SMA ($) 3.554
12-1 Month Momentum % -66.16
52-Week Range ($) 2.89 - 14.55
Shares Outstanding (Mil) 267.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pacific Biosciences of California Inc Filings

Filing Date Document Date Form
No Filing Data

Pacific Biosciences of California Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Pacific Biosciences of California Inc Frequently Asked Questions

What is Pacific Biosciences of California Inc(PACB)'s stock price today?
The current price of PACB is $2.84. The 52 week high of PACB is $14.55 and 52 week low is $2.89.
When is next earnings date of Pacific Biosciences of California Inc(PACB)?
The next earnings date of Pacific Biosciences of California Inc(PACB) is 2024-05-02 Est..
Does Pacific Biosciences of California Inc(PACB) pay dividends? If so, how much?
Pacific Biosciences of California Inc(PACB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1